F27. EFFICACY OF MONTHLY EXTENDED-RELEASE RISPERIDONE INJECTIONS (RBP-7000) FOR THE TREATMENT OF SCHIZOPHRENIA: AN ANALYSIS OF INDIVIDUAL PANSS ITEMS

BACKGROUND: RBP-7000 (PERSERIS™), a once-monthly subcutaneous extended-release risperidone formulation approved for the treatment of schizophrenia in adults, was designed to deliver clinically relevant plasma concentrations on the first day of dosing (with no loading or supplemental dosing required)...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Schizophr Bull
Main Authors: Andorn, Anne, Graham, Jay, Fava, Maurizio, Csernansky, John, Newcomer, John W, Walling, David, Shinde, Sunita, Muma, Gilbert, Heidbreder, Christian
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2019
Assuntos:
Poster Session II
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6455665/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/schbul/sbz018.439
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados